Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Lipocine Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Lipocine Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Grissinger Michael | Director | – | Aug 7, 2026 | 1 |
| Patel Mahesh V. | Chief Executive Officer | 160,679 | Jun 30, 2026 | 5 |
| Higuchi John W. | Director | 203,797 | Jun 4, 2026 | 3 |
| Ono Richard Dana | Director | 14,125 | Jun 4, 2026 | 1 |
| Jene Jill M. | Director | – | Jun 4, 2026 | 1 |
| Fogarty Krista | Principal Accounting Officer | 1,727 | Dec 19, 2025 | 1 |
| Fink Jeffrey Arvin | Director | – | Jun 5, 2025 | 0 |
| Papapetropoulos Spyridon | Director | 21,739 | Jun 5, 2025 | 0 |
| Nomikos George | Chief Medical Officer | – | Nov 8, 2022 | 0 |
| Brown Morgan R | Chief Financial Officer | – | Dec 8, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 7, 2026 (view filing) | Apr 7 | Same day | Higuchi John W.Director | PPurchase | +40.0K | $2.03 | +$81.2K | +24.4%203.8K after | |
| Apr 6, 2026 (view filing) | Apr 6 | Same day | Higuchi John W.Director | PPurchase | +123.0K | $2.05 | +$252.2K | +301.5%163.8K after | |
| Apr 6, 2026 (view filing) | Apr 6 | Same day | Patel Mahesh V.Chief Executive Officer | PPurchase | +25.0K | $2.03 | +$50.8K | +18.4%160.7K after | |
| Apr 2, 2026 (view filing) | Apr 2 | Same day | Patel Mahesh V.Chief Executive Officer | PPurchase | +25.0K | $2.02 | +$50.5K | +22.6%135.7K after | |
| May 25, 2023 (view filing) | May 25 | Same day | Patel Mahesh V.CEO and President | PPurchase | +8.71K | $5.03 | +$43.8K | +8.8%107.4K after | |
| Mar 24, 2023 (view filing)5:28 PM ET | Mar 24 | Same day | Patel Mahesh V.CEO and President | PPurchase | +150.0K | $0.32 | +$48.0K | +9.8%1.68M after | |
| Mar 20, 2023 (view filing)6:51 PM ET | Mar 20 | Same day | Ono Richard DanaDirector | PPurchase | +4.00K | $0.34 | +$1.36K | +39.5%14.1K after | |
| Mar 17, 2023 (view filing)4:31 PM ET | Mar 17 | Same day | Patel Mahesh V.CEO and President | PPurchase | +50.0K | $0.33 | +$16.5K | +3.4%1.53M after | |
| Nov 28, 2022 (view filing)4:33 PM ET | Nov 22 | 6 daysLate | Papapetropoulos SpyridonDirector | PPurchase | +21.7K | $0.47 | +$10.2K | New position21.7K after | |
| Nov 14, 2022 (view filing)3:58 PM ET | Nov 14 | Same day | Patel Mahesh V.CEO and President | PPurchase | +75.0K | $0.39 | +$29.3K | +5.3%1.48M after | |
| Sep 27, 2022 (view filing)6:53 PM ET | Sep 27 | Same day | Patel Mahesh V.CEO and President | PPurchase | +100.0K | $0.41 | +$41.0K | +7.7%1.40M after | |
| May 17, 2022 (view filing) | May 17 | Same day | Fogarty KristaPrincipal Accounting Officer | PPurchase | +12.5K | $0.86 | +$10.8K | New position12.5K after | |
| May 16, 2022 (view filing) | May 16 | Same day | Patel Mahesh V.CEO and President | PPurchase | +50.0K | $0.77 | +$38.5K | +4.0%1.30M after | |
| Nov 18, 2021 (view filing) | Nov 18 | Same day | Patel Mahesh V.CEO and President | PPurchase | +25.0K | $1.09 | +$27.3K | +2.0%1.25M after |